PATTIES FOODS - Frankfurt Stock Exchang

F:PH4 Germany Biotechnology
Market Cap
$1.15 Billion
€1.12 Billion EUR
Market Cap Rank
#8340 Global
#897 in Germany
Share Price
€0.77
Change (1 day)
-0.65%
52-Week Range
€0.23 - €1.35
All Time High
€1.35
About

CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more

PATTIES FOODS - Frankfurt Stock Exchang (PH4) - Net Assets

Latest net assets as of June 2025: €315.04 Million EUR

Based on the latest financial reports, PATTIES FOODS - Frankfurt Stock Exchang (PH4) has net assets worth €315.04 Million EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.19 Billion) and total liabilities (€876.86 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €315.04 Million
% of Total Assets 26.43%
Annual Growth Rate -40.76%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 26.99

PATTIES FOODS - Frankfurt Stock Exchang - Net Assets Trend (2020–2024)

This chart illustrates how PATTIES FOODS - Frankfurt Stock Exchang's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for PATTIES FOODS - Frankfurt Stock Exchang (2020–2024)

The table below shows the annual net assets of PATTIES FOODS - Frankfurt Stock Exchang from 2020 to 2024.

Year Net Assets Change
2024-12-31 €363.87 Million -20.35%
2023-12-31 €456.83 Million +1.67%
2022-12-31 €449.33 Million -62.77%
2021-12-31 €1.21 Billion -59.15%
2020-12-31 €2.95 Billion --

Equity Component Analysis

This analysis shows how different components contribute to PATTIES FOODS - Frankfurt Stock Exchang's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 911093400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components €9.47 Billion 2603.89%
Total Equity €363.87 Million 100.00%

PATTIES FOODS - Frankfurt Stock Exchang Competitors by Market Cap

The table below lists competitors of PATTIES FOODS - Frankfurt Stock Exchang ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in PATTIES FOODS - Frankfurt Stock Exchang's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 456,830,000 to 363,871,000, a change of -92,959,000 (-20.3%).
  • Net loss of 91,207,000 reduced equity.
  • New share issuances of 74,000 increased equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-91.21 Million -25.07%
Share Issuances €74.00K +0.02%
Other Changes €-1.83 Million -0.5%
Total Change €- -20.35%

Book Value vs Market Value Analysis

This analysis compares PATTIES FOODS - Frankfurt Stock Exchang's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.68x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.30x to 2.68x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 €2.52 €0.77 x
2021-12-31 €1.02 €0.77 x
2022-12-31 €0.38 €0.77 x
2023-12-31 €0.36 €0.77 x
2024-12-31 €0.29 €0.77 x

Capital Efficiency Dashboard

This dashboard shows how efficiently PATTIES FOODS - Frankfurt Stock Exchang utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -25.07%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -22.40%
  • • Asset Turnover: 0.29x
  • • Equity Multiplier: 3.83x
  • Recent ROE (-25.07%) is above the historical average (-101.35%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 -41.33% -117.54% 0.28x 1.27x €-1.52 Billion
2021 -159.08% -787.84% 0.11x 1.88x €-2.04 Billion
2022 -200.90% -187.53% 0.29x 3.65x €-947.61 Million
2023 -80.39% -79.17% 0.28x 3.64x €-412.92 Million
2024 -25.07% -22.40% 0.29x 3.83x €-127.59 Million

Industry Comparison

This section compares PATTIES FOODS - Frankfurt Stock Exchang's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $1,291,084,078
  • Average return on equity (ROE) among peers: -24.49%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
PATTIES FOODS - Frankfurt Stock Exchang (PH4) €315.04 Million -41.33% 2.78x $777.98 Million
09R (09R) $-3.01 Million 0.00% 0.00x $11.12 Million
IDORSIA AG (19T) $-968.72 Million 0.00% 0.00x $532.51 Million
1S90 (1S90) $-44.86 Million 0.00% 0.00x $51.72 Million
Strategic Partners A/S (1TB0) $14.24 Million -182.90% 0.36x $1.31 Million
25K0 (25K0) $-16.66 Million 0.00% 0.00x $102.39 Million
2BO (2BO) $-37.78 Million 0.00% 0.00x $6.23 Million
Intervacc AB (publ) (2E9) $237.93 Million -43.23% 0.09x $3.46 Million
2F5 (2F5) $-4.57 Million 0.00% 0.00x $2.14 Million
2H0 (2H0) $14.92 Million -17.30% 0.56x $9.25 Million
GNI Group Ltd (3G6) $13.72 Billion -1.46% 0.26x $772.60 Million